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662Objective: Selective antegrade cerebral perfusion (ACP) during hypothermic circulatory arrest (HCA) provides
cerebral protection during aortic arch surgery. However, the ideal temperature for HCA during ACP remains
unknown. Clinical outcomes were compared in patients who underwent moderate (nasopharyngeal temperature,
20C) versus deep (nasopharyngeal temperature,<20C) HCAwith ACP during aortic arch repair.
Methods: By using a prospectively maintained clinical database, we analyzed data from 221 consecutive
patients who underwent aortic arch replacement with HCA and ACP between December 2006 and May
2009. Seventy-eight patients underwent deep hypothermia (mean lowest temperature, 16.8C  1.7C) and
143 patients underwent moderate hypothermia (mean, 22.9C  1.4C) before systemic circulatory arrest
was initiated. Multivariate stepwise logistic and linear regressions were performed to determine whether depth
of hypothermia independently predicted postoperative outcomes and blood-product use.
Results: Compared with moderate hypothermia, deep hypothermia was associated independently with a greater
risk of in-hospital death (7.7% vs 0.7%; odds ratio [OR], 9.3; 95% confidence interval [CI], 1.1-81.6; P¼ .005)
and 30-day all-cause mortality (9.0% vs 2.1%; OR, 4.7; 95% CI, 1.2-18.6; P ¼ .02), and with longer cardio-
pulmonary bypass time (154  62 vs 140  46 min; P ¼ .008). Deep hypothermia also was associated with
a higher incidence of stroke, although this association was not statistically significant (7.6% vs 2.8%;
P¼ .073; OR, 4.3; 95% CI, 0.9-12.5). No difference was seen in acute kidney injury, blood product transfusion,
or need for surgical re-exploration.
Conclusions: Moderate hypothermia with ACP is associated with lower in-hospital and 30-day mortality,
shorter cardiopulmonary bypass time, and fewer neurologic sequelae than deep hypothermia in patients who un-
dergo aortic arch surgery with ACP. (J Thorac Cardiovasc Surg 2013;146:662-7)Hypothermic circulatory arrest (HCA) has been used for
decades for cerebral protection during aortic arch surgery.
HCA creates a motionless, bloodless field; minimizes the
need for aortic clamping; and provides neuroprotection by
reducing the cerebral metabolic rate, excitatory transmitter
release, ion influx, and vascular permeability.1 However, the
ideal temperature for HCA remains unknown. Prolonged
deep HCA (DHCA) has been associated with increased coa-
gulopathy, inflammatory response, vascular endothelial
dysfunction, apoptosis, and stroke risk.2-4 Interestingly,e Departments of Anesthesiologya and Surgery,b Baylor College of Medicine;
ivisions of Cardiovascular Anesthesiology,c Cardiovascular Surgery,d Biosta-
and Epidemiology,e and Pathology,f the Texas Heart Institute at St. Luke’s
opal Hospital, Houston, Tex.
was provided solely by institutional and departmental sources.
res: Authors have nothing to disclose with regard to commercial support.
d for publication Aug 30, 2012; revisions received Feb 18, 2013; accepted for
ation March 5, 2013; available ahead of print April 3, 2013.
for reprints: Wei Pan, MD, Department of Cardiovascular Anesthesiology,
xas Heart Institute at St. Luke’s Episcopal Hospital, PO Box 20345, Houston,
7030 (E-mail: wpan@texasheart.org).
23/$36.00
ht  2013 by The American Association for Thoracic Surgery
.doi.org/10.1016/j.jtcvs.2013.03.004
The Journal of Thoracic and Cardiovascular Surgstudies have suggested that deep hypothermia alone
without circulatory arrest also may be associated with
increased inflammatory response and neurologic damage.5-7
With the advent of antegrade cerebral perfusion (ACP)
during HCA to provide some measure of uninterrupted
cerebral perfusion during aortic arch repair, the desired tem-
perature level for HCA has become even more unclear.
Indeed, moderate HCA (MHCA) (nasopharyngeal temper-
ature, 20C) still may afford cerebral protection while
minimizing the side effects of DHCA (nasopharyngeal tem-
perature,<20C). To address this question, we compared
clinical outcomes in patients who underwent MHCAversus
DHCAwith selective ACP during aortic arch repair.MATERIALS AND METHODS
Study Design
Institutional review board approval and informed patient consent were
obtained for the prospective collection and subsequent analysis of clinical
data. We identified 243 consecutive patients who underwent aortic arch
repair between December 2006 and May 2009 at the Texas Heart Institute
at St. Luke’s Episcopal Hospital (Houston, Tex). Both HCA and selective
ACP were used in all patients. Patients who received aprotinin intraopera-
tively (n ¼ 22) were excluded from further analysis because of this drug’sery c September 2013
Abbreviations and Acronyms
ACP ¼ antegrade cerebral perfusion
AKI ¼ acute kidney injury
AKIN ¼ Acute Kidney Injury Network
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
HCA ¼ hypothermic circulatory arrest
LOS ¼ length of stay
MHCA ¼ moderate hypothermic circulatory arrest
MI ¼ myocardial infarction
OR ¼ odds ratio
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Madverse effects on renal function and mortality risk.8 The 221 remaining
patients were divided into 2 groups: DHCA (lowest nasopharyngeal tem-
perature,<20C; n¼ 78) andMHCA (lowest nasopharyngeal temperature,
20C; n ¼ 143).
Data Collection
Patient demographics, perioperative risk factors, and the incidence of ad-
verse clinical outcomes were abstracted from a prospectively maintained
clinical database. Preoperative renal function was assessed by using the
abbreviated Modification of Diet in Renal Disease study equation to calcu-
late each patient’s estimated glomerular filtration rate.9 Patient temperature
was defined as the lowest recorded intraoperative nasopharyngeal tempera-
ture, which generally coincidedwith HCA initiation.Measured adverse out-
comes included in-hospital mortality, 30-day all-cause mortality, stroke,
myocardial infarction (MI), acute kidney injury (AKI), and postoperative
bleeding that necessitated reoperation.A diagnosis ofMIwasmade if the re-
cords showed newQwaves (Minnesota code, 1-1-1 to 1-2-7), new persistent
ST-segment or T-wave changes (Minnesota code, 4-1, 4-2, 5-1, 5-2, or 9-2),
increased levels of the muscle-brain isoenzyme of creatine kinase, or evi-
dence of acuteMI on autopsy. Strokewas diagnosed if therewas clinical ev-
idence of it or if a new focal or global defect was observed on computed
tomography, magnetic resonance imaging, or autopsy. Postoperative AKI
was defined according to Risk, Injury, Failure, Loss, and End-stage kidney
diseases criteria10 and Acute Kidney Injury Network (AKIN) classifica-
tion.11 Survivors’ hospital length of stay (LOS)was computed as the number
of days between procedure and discharge, including any time patients spent
at hospitals or long-term acute care facilities after transfer from our institu-
tion. The number of units of packed red blood cells, fresh-frozen plasma,
pooled platelets, platelet apheresis, and cryoprecipitate administered within
48 hours of surgery was collected from blood bank records.
Surgical and Anesthetic Technique
All patients underwent aortic arch replacement to treat aortic arch aneu-
rysm or dissection. Before general anesthesia was induced, 2-channel
near-infrared spectroscopy (INVOS System; Somanetics, Troy, Mich)
noninvasive probes were placed on the forehead, approximating the frontal
lobes bilaterally. The near-infrared spectroscopy then was monitored
throughout surgery. General anesthesia was performed in a standardized
fashion with etomidate, midazolam, fentanyl, and isoflurane. Before inci-
sion, patients received either aminocaproic acid or tranexamic acid as an
antifibrinolytic.
All surgeries involved the use of HCAwith selective ACP. Ninety-four
percent of patients had either axillary artery cannulation or direct innomi-
nate artery cannulation to establish cardiopulmonary bypass (CPB). This
was the case in 95% of elective procedures and 91% of urgent or emergentThe Journal of Thoracic and Caprocedures. After systemic heparinization (300 IU/kg), CPB and systemic
cooling were initiated. For CPB, pH-stat principles of acid-base manage-
ment were used. Repeated administration of cold cardioplegia solution
and topical cooling were used for myocardial protection. During cooling,
100 mg lidocaine, 100 mg esmolol, 150 mg amiodarone, and 2 mg magne-
sium were administered routinely through the central line. In the DHCA
group, cooling continued until electrocerebral silence was seen on multi-
channel electroencephalography (mean nasopharyngeal temperature,
16.8C  1.7C). Starting in January 2008, the target temperature for
HCA was increased to 23C; all patients treated after this change was
made were included in the MHCA group.
In patients undergoing total aortic arch repair, the Y-graft technique (ie,
arch replacement with bifurcated or trifurcated grafts) was used.12 Briefly,
2 of the branches of the Y-graft were sutured to the left subclavian artery
and the left common carotid artery during the cooling phase. Upon reach-
ing the target temperature, 500 mg of thiopental was administered, the
patient’s head was packed in ice, and HCAwas initiated with ACP (target
flow, 10-20 mL/kg/min) via the right axillary artery (by clamping the
innominate artery) and, sometimes, 1 or more branches of the Y-graft
(Figure 1). The innominate artery then was divided and sewn to the distal
end of the Y-graft. After the branch artery anastomoses were completed, the
innominate artery clamp was removed and a clamp was placed on the prox-
imal aspect of the Y-graft, restoring flow from the axillary artery to the
attached brachiocephalic arteries. Graft replacement of the ascending aorta
and transverse aortic arch then was performed.
After the distal aortic anastomosis was completed, CPB flow to the
lower bodywas restarted through the axillary artery (in partial arch replace-
ment cases) or a side branch of the arch graft (in total arch replacement
cases). After the repair was completed, the patient was warmed to
36.5C (avoiding blood-bath gradients of>10C) and weaned from CPB.
Perioperative blood products were transfused according to the attending
physician’s judgment, taking into account the patient’s clinical status and
available laboratory values.
Statistical Analysis
All statistical analyseswere performedwith SASstatistical software (ver-
sion 9.1; SAS Institute, Cary, NC) in the Division of Biostatistics and Epide-
miology at the Texas Heart Institute (Houston, Tex). Continuous variables
were expressed as the mean standard deviation, and categoric (frequency)
variables were expressed as percentages. Univariate logistic regression anal-
yses initially were conducted to test for between-group differences in patient
preoperative demographics, risk factors, and preoperative medications
(Table 1). Categoric variableswere analyzedwith thec2 or Fisher exact tests.
Continuous variables first were examined for normality of distribution: the
t test was used for those variableswith normal distributions, and the nonpara-
metricWilcoxon rank-sumtestwas applied for thevariableswith skeweddis-
tributions. In all tests, 2-tailed P values were calculated.
To control for demographic factors, medications, and perioperative risk
factors, multivariate stepwise logistic regression was performed on all pa-
tient data to determine whether DHCAwas associated independently with
worse postoperative outcomes than MHCA. Linear regression was used to
determine whether DHCA was associated independently with prolonged
CPB time, LOS, and increased blood product use.RESULTS
Patient demographics and perioperative risk factors are
presented in Table 1. Patients in theMHCA group had amar-
ginally higher preoperative prevalence of pulmonary disease
(P ¼ .07) and were more likely to undergo total arch repair
(P ¼ .07) than patients in the DHCA group. Of note, the
groups did not significantly differ with respect to age, gender
distribution, diabetes, history of smoking, renal insufficiency,rdiovascular Surgery c Volume 146, Number 3 663
FIGURE 1. Cerebral perfusion approach used during hypothermic circu-
latory arrest.
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Mhypertension, coronary artery disease, congestive heart fail-
ure, New York Heart Association class III/IV, history of
stroke, emergent or urgent surgery, prior sternotomy, prior
aortic surgery, or preoperative medications. Although HCA
duration was not significantly different between groups, theTABLE 1. Demographic variables and risk factors in patients
(N ¼ 221) undergoing aortic arch repair with DHCA or MHCAwith
antegrade cerebral perfusion
Demographic variables and risk
factors
DHCA
(n ¼ 78)
MHCA
(n ¼ 143) P
Age, y 61  14 60  15 .42
Female sex,% 38 32 .35
Diabetes mellitus,% 9 6 .34
Preop serum creatinine level, mg/dL 1.25  1.03 1.26  0.98 .95
Renal insufficiency,% 14 13 .87
Smoking history,% 33 41 .29
Hypertension,% 87 87 .92
Carotid disease,% 15 12 .46
Pulmonary disease,% 26 38 .07
Coronary artery disease,% 30 37 .29
Congestive heart failure,% 15 18 .60
NYHA class III/IV,% 33 36 .70
History of stroke,% 8 12 .33
Hemiarch or partial arch surgery,% 76 64 .07
Total arch surgery,% 24 36 .07
Emergent surgery,% 14 13 .87
Urgent surgery,% 12 12 .94
Prior sternotomy,% 28 36 .26
Acute aortic dissection,% 14 13 .87
First open aortic surgery,% 65 59 .33
CPB duration, min 154  62 140  46 .008
HCA duration, min 37  23 38  25 .68
ß-Blocker,% 67 70 .62
Statins,% 37 40 .70
NYHA, New York Heart Association; DHCA, deep hypothermic circulatory arrest;
MHCA, moderate hypothermic circulatory arrest; CPB, cardiopulmonary bypass;
HCA, hypothermic circulatory arrest.
664 The Journal of Thoracic and Cardiovascular SurgDHCA group had significantly longer CPB times than the
MHCA group (154  62 vs 140  47 min; P ¼ .008).
Postoperative outcomes are summarized in Table 2.
There were 7 in-hospital deaths (6 in the DHCA group
and 1 in the MHCA group). Multiorgan system failure
was the most common cause of death. There were 3 addi-
tional 30-day all-cause deaths (1 in the DHCA group and
2 in the MHCA group). To determine whether DHCA was
associated independently with a significantly higher risk
of in-hospital death and 30-day all-cause mortality, multi-
variate stepwise logistic analysis was performed, control-
ling for patient demographics, preoperative risk factors,
and intraoperative variables. Deep HCAwas associated in-
dependently with higher risks of in-hospital death (8% vs
1%; P ¼ .005) and 30-day all-cause mortality (9% vs
2%; P ¼ .02) than MHCA.
The incidence of stroke in the DHCA group was 3-fold
higher than in the MHCA group (8% vs 3%; P ¼ .07;
odds ratio [OR], 3.4; 95% confidence interval [CI], 0.9-
12.6). However, the difference between groups did not
reach statistical significance (probably because of the small
sample size). There were 3 transient and 3 permanent
strokes in the DHCA group, compared with 2 transient
and 2 permanent strokes in the MHCA group. With respect
to spinal cord injury, no paraplegia was observed in either
group. Likewise, no significant differences between groups
were observed with respect to the incidence of postopera-
tive MI, atrial fibrillation, respiratory failure, need for post-
operative tracheotomy, and postoperative bleeding
necessitating reoperation (Table 2).
In terms of renal outcomes, in the DHCA group the mean
serum creatinine levels were 1.25  1.03 mg/dL preopera-
tively and 1.31 0.64 mg/dL postoperatively, with an aver-
age change in value of 0.06  0.60 mg/dL. In the MHCA
group, creatinine levels were 1.26  0.98 mg/dL preopera-
tively and 1.43 0.95 mg/dL postoperatively, with an aver-
age change of 0.15  0.72 mg/dL. In the DHCA group, 11
patients (14%) had preoperative renal dysfunction, 13 pa-
tients (17%) had postoperative AKI defined by AKIN crite-
ria, 2 patients (3%) required temporary hemodialysis, and
none required dialysis after discharge. In the MHCA group,
19 patients (13%) had preoperative renal dysfunction, 27
patients (19%) had postoperative AKI defined by AKIN
criteria, 2 patients (1%) required temporary hemodialysis,
and 1 patient (1%) required dialysis after discharge. There
were no significant differences in postoperative renal out-
comes between the 2 groups.
Multivariate linear regression was performed for out-
comes with continuous values. The mean LOS was
16  13 days in the DHCA group versus 14  12 days in
the MHCA group (P ¼ .39). No significant difference was
observed between groups in the amount of transfused
packed red blood cells, fresh-frozen plasma, platelets
(pooled and apheresis), or cryoprecipitate used (Table 3).ery c September 2013
TABLE 2. Postoperative outcomes in patients (N ¼ 221) undergoing aortic arch repair with DHCA or MHCAwith antegrade cerebral perfusion
Postoperative outcome DHCA (n ¼ 78) MHCA (n ¼ 143) P OR 95% CI
30-d mortality,% 9 2 .02 4.7 1.2-18.6
In-hospital death,% 8 1 .005 9.3 1.1-81.6
Stroke,% 8 3 .09 3.4 0.9-12.6
Postoperative MI,% 1 1 .6 0.5 0.3-7.6
Bleeding necessitating reoperation,% 3 7 .27 0.4 0.1-2.0
Hospital stay, d 16  12 14  12 .39 — —
Postoperative serum creatinine level, mg/dL 1.31  0.64 1.43  0.95 .30 — —
Preoperative-postoperative change in serum creatinine, mg/dL 0.06  0.60 0.15  0.72 .38 — —
Postoperative AKI by AKIN criteria,% 17 19 .89 1.0 0.4-2.0
Postoperative AKI by RIFLE criteria,% 12 12 .94 1.0 0.4-2.4
Postoperative dialysis,% 3 2 .84 0.8 0.1-5.9
RIFLE, Risk, Injury, Failure, Loss, and End-stage kidney diseases; DHCA, deep hypothermic circulatory arrest;MHCA,moderate hypothermic circulatory arrest;OR, odds ratio;
CI, confidence interval; MI, myocardial infarction; AKI, acute kidney injury; AKIN, acute kidney injury network.
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MDISCUSSION
The ideal HCA temperature for surgical repair of the aor-
tic arch during ACP remains unclear. Although previous an-
imal and clinical studies have suggested that MHCA with
ACP may be associated with better neurologic outcomes
than DHCA,3,13-16 other investigators have not confirmed
these findings.17-19 Our data suggest that MHCA with
ACP is associated with lower hospital and 30-day mortality
rates, shorter CPB time, and fewer neurologic sequelae than
DHCA, after adjustment for patient demographics, preoper-
ative risk factors and medications, and intraoperative vari-
ables. The 30-day all-cause mortality rate was 4-fold
higher in patients who underwent DHCAwith ACP instead
of MHCAwith ACP. The stroke incidencewas nearly 3-fold
higher in the DHCA group than in theMHCA group (8% vs
3%), although this difference was not significant.
Since the introduction of aortic arch replacement in the
1950s by DeBakey and Cooley,20 the 2 main methods of
brain protection during this procedure have been different
degrees of hypothermia and adjuncts for cerebral perfusion.
Deep HCA at a body temperature of 18C was first used for
successful aortic arch reconstruction in 1975.21 Because
DHCA dramatically reduces cerebral oxygen requirements,
it enabled the development of modern aortic surgery. How-
ever, because the safe duration of arrest is limited by the risk
of neurologic sequelae,4 restricting arch exclusion to 30 toTABLE 3. Perioperative transfusion requirements (48 hr) in patients
(N ¼ 221) undergoing surgical aortic arch repair with DHCA or
MHCAwith antegrade cerebral perfusion
Perioperative transfusion DHCA (n ¼ 78) MHCA (n ¼ 143) P
Packed red blood cells, units 5.6  5.3 4.6  4.2 .15
Fresh-frozen plasma, units 5.4  5.7 4.6  4.5 .24
Pooled platelets, units 11.5  12.5 13.3  10.7 .28
Apheresis platelets, doses 1.2  1.8 1.1  1.7 .89
Pooled cryoprecipitate, doses 0.9  1.3 1.1  1.1 .23
DHCA, Deep hypothermic circulatory arrest;MHCA,moderate hypothermic circula-
tory arrest.
The Journal of Thoracic and Ca40 minutes has emerged as a guideline for the safe use of
an HCA-only strategy.22 In the 1990s, efforts to extend
the protected time for aortic arch repair produced the con-
cepts of ACP and retrograde cerebral perfusion, which
were used during HCA.12,23 Both techniques continue to
have their proponents, but retrograde cerebral perfusion
seems to have fallen out of favor in the past decade.
Multiple studies have shown that ACP extends the safe
duration of arch intervention beyond what HCA alone
provides,24,25 especially when the distal arch repair
extends beyond 30 minutes. However, the ideal core
temperature for HCAwith ACP has yet to be determined.
In an effort to improve patient outcomes after aortic arch
replacement, we examined the impact of the temperature
used during HCAwith ACP on specific perioperative mea-
sures. We found that temperature lower than 20Cwas asso-
ciated with a 9-fold increase in hospital death, as well as
significant increases in 30-day mortality rates and CPB
time and a trend toward an increased stroke incidence. Tem-
perature did not, however, have a significant effect on trans-
fusion requirements or postoperative renal function. We
chose 20C as the division between moderate and deep hy-
pothermia because a body temperature lower than 20C
commonly is defined as profound or deep hypothermia,
and because the cooling continued until electrocerebral
silence was seen on multichannel electroencephalography.
Although temperatures of approximately 23C would char-
acterize severe hypothermia in the general population, such
temperatures are more moderate than the temperatures
traditionally achieved during HCA.
Although deep hypothermia confers the benefit of mini-
mizing metabolic demand when energy substrates are lim-
ited, this level of hypothermia may have many adverse
effects. Evidence from both clinical and animal studies sug-
gests that deep hypothermia with rewarming alone is asso-
ciated with neuronal injury.7 Furthermore, Warren et al7
reported that neuronal death from deep hypothermia and
rewarming was caused by adenosine triphosphate loss,rdiovascular Surgery c Volume 146, Number 3 665
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Mglutamate receptor activation, and Ca2þ influx. Deep hypo-
thermia also may impair microvascular perfusion and
disrupt the blood-brain barrier.2,13 Larger vessels may be
affected by deep hypothermia as well. One group reported
that the antegrade cerebral blood flow shunted away from
capillaries increases during deep hypothermia.26 These
effects may explain some of our DHCA patients’ adverse
outcomes. Our findings also may reflect a more systemic
underlying process that is triggered by deep hypothermia
on CPB, such as inflammation that leads to organ damage.6
Shorter CPB times secondary to a shorter rewarming period
in the MHCA group may result in less cellular injury,
quicker recovery, and less early mortality risk. Interestingly,
Khaladj et al14 found that hypothermia at 20C provides
better brain protection than a profound hypothermic tem-
perature of 10C in a pig model of HCAwith ACP. Further-
more, it has been reported that mild or moderate cerebral
hypothermia induced immediately after cardiac arrest
improves cerebral outcome, whereas deep hypothermia
can worsen cerebral and cardiac outcomes.27 It is unlikely
that our results are related directly to differences in surgical
technique because the same surgical team performed all of
the surgeries. In addition, the lowest temperature was stan-
dardized during each era of the study and was not applied
selectively to certain (eg, sicker) patients.
Although DHCA prolongs CPB time and may reduce the
activity of enzymes involved in platelet activation pathways
and clotting factors, both of which can increase transfusion
requirements after DHCA,3 the transfusion requirement did
not differ significantly between the DHCA and MHCA
groups. Similarly, there was no observed difference in the
incidence of surgical re-exploration. Although these data
suggest that choosing DHCA or MHCA does not affect
the rate of transfusion or bleeding complications, these
data have to be interpreted with caution because of our
study’s relatively small sample size.
Although ACP provides energy substrates to the brain
during HCA, the rest of the body is subjected to total ische-
mia. Indeed, vascular endothelial dysfunction and apopto-
sis resulting from CPB and whole-body systemic
ischemia-reperfusion have been implicated in the patho-
physiology of multisystem organ failure after DHCA.2
Therefore, we evaluated renal function by measuring pre-
operative and postoperative serum creatinine levels to
examine the renal effects of HCA at more moderate tem-
peratures. No significant differences were observed in the
risk of postoperative AKI (according to the AKIN and
Risk, Injury, Failure, Loss, and End-stage kidney diseases
criteria) between the moderate and deep HCA groups. Sim-
ilarly, with respect to spinal cord injury, no difference in the
paraplegia incidence was observed in either group.
Together, these data suggest that lower-body end-organs
can tolerate brief periods of ischemia when moderate
HCA is used for aortic arch surgery.666 The Journal of Thoracic and Cardiovascular SurgThis study was limited in that it was a retrospective
cohort study from a single institution. Most patients who
underwent surgery earlier in the study period were exposed
to deep hypothermia, whereas the more recent patients un-
derwent moderate hypothermia. Therefore, it is possible
that perioperative management techniques changed slightly
over time, potentially biasing our results. In contrast, all of
the surgeries were performed by a single surgeon with many
years of experience in aortic arch surgery; therefore, it is un-
likely that any changes over time in surgeon technique or
skill affected the results. Also, although all patients with
overt clinical evidence of stroke underwent a cerebral imag-
ing study to confirm the stroke, cerebral imaging was not
performed in patients without clinical indicators of stroke.
Some regions of the brain, such as the pons and the cerebel-
lum, may be more sensitive to ischemic injury, and subtle
clinical changes in these areas may not have been detected
and recorded.28 In addition, despite our careful use of logis-
tic regression models to adjust for potential confounders
that may have affected outcomes, other immeasurable fac-
tors nonetheless may have biased the results.
In conclusion, this study showed that, in patients who un-
dergo aortic arch surgery, MHCA with ACP is associated
with lower hospital and 30-day mortality rates, shorter
CPB time, and fewer neurologic sequelae than DHCA.
However, MHCA and DHCA are associated with similar
transfusion requirements and postoperative renal function.
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